trial · primary record
ATL-RIC
Peripheral T-cell Lymphomas
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 118 |
| Primary completion | 2030-10-31 |
| Primary endpoint | Progression-free survival (PFS) of HCT recipients on the RIC arm and the mRIC arm |
| Registry ID | NCT03922724 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:09.378Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03922724
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.